We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Requirements to participate in haemophilia clinical trials.
- Authors
Mahlangu, Johnny N.
- Abstract
Introduction: Clinical trials in haemophilia product development are expanding rapidly however, the number of sites and expertise in the clinical trial conduct is limited. Guidance on the requirement for conducting clinical trials is required Aim: The aim of this paper is to outline generic requirements to participate in clinical trials in haemophilia Materials: This paper describes three elements which are the requirements for success conduct of haemophilia clinical trials. These are the study product, study participant, and the global regulatory and ethics framework Results and conclusion: In haemophilia clinical trials, requirements for participate in studies are many and include considerations of study product, study participant and ethical and regulatory framework. When these elements are in place, it is possible to conduct haemophilia clinical trials anywhere in the world.
- Subjects
HEMOPHILIA; CLINICAL trials; NEW product development; TECHNICAL specifications
- Publication
Haemophilia, 2020, Vol 26, p22
- ISSN
1351-8216
- Publication type
Article
- DOI
10.1111/hae.13886